Drug intelligence / Profile preview

Shuxin Granules

Development stage: Unknown
Lead developer: Liaoning Hancaotang Traditional Chinese Medicine
Modality: Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Shuxin Granules (舒心颗粒) is a traditional Chinese medicine (TCM) herbal formulation developed and manufactured by Liaoning Hancaotang Traditional Chinese Medicine. Presented as oral granules, the product is indicated for cardiovascular support and 'heart-soothing' according to traditional Chinese medical concepts. As a traditional herbal formulation, it does not have a single defined molecular target or mechanism of action in the Western pharmaceutical sense, instead relying on the synergistic properties of its herbal components. It is an approved product in China for the treatment of cardiovascular-related symptoms.

Brand names: Shuxin Granules
Other names: 舒心颗粒Shuxin Keli

Beyond the preview

Go deeper on Shuxin Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shuxin Granules.

Explore the full profile